CHUTCHATORN PIMSUPARP: Open Payments
NPI 1720735392 · SANTA ANA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,258 in 80 payments from 16 companies in 2025. Trend: 2023 $2,588 · 2024 $2,590 · 2025 $2,258
Food & beverage: $2,258
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $495 |
| GENZYME CORPORATION | 7 | $325 |
| UCB, Inc. | 17 | $227 |
| Galderma Laboratories, L.P. | 4 | $206 |
| Amgen Inc. | 5 | $174 |
| Janssen Biotech, Inc. | 7 | $174 |
| Organon LLC | 2 | $152 |
| LEO Pharma Inc. | 5 | $131 |
| Novartis Pharmaceuticals Corporation | 3 | $88 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $80 |
Products named: DUPIXENT, RINVOQ, Bimzelx, NEMLUVIO, Otezla, TREMFYA, BOTOX, VTAMA.
Industry payments across CA — which companies pay providers there.
